EN

Systemic Lupus Erythematosus – SLE

Systemic Lupus Erythematosus – SLE

Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder, characterized by a wide spectrum of clinical manifestations that can affect many organs, including the skin, joints, the central nervous system and the kidneys. Rare, inherited, single-gene complement deficiencies are strongly related to SLE, but the disease is inherited during a polygenic manner in most patients. because of the heterogeneity of SLE, Diagnosis remains challenging through a combination of clinical and laboratory criteria.

Panel test

  • Immunologic tests:
  • Complement 3, 4, and CH50 – Low levels of complement in the blood are often linked with lupus.
  • Antinuclear antibody (ANA) test – it’s an initial screen (not disease-specific); In patients with a positive ANA, more tests are performed for other antibodies that can confirm the diagnosis.
  • Double-stranded DNA (dsDNA) – Presence of high antibody titers to native dsDNA is specific and diagnostic for SLE
  • Extractable nuclear antigens:
    • Smith (Sm) antibodies – highly specific for SLE but occur in only 30-35% of cases
    • Ribonucleic protein (RNP) antibodies – not specific for SLE
    • Anti-Sjögren’s syndrome antigen A (SSA, or Ro) and anti-Sjögren syndrome antigen B (SSB, or La) antibodies – not specific for SLE
  • Histone antibodies – This test is useful for when drug-induced lupus is suspected
  • Anti-ribosomal P (anti-P) – related to neurolupus but not useful in diagnosis of neuropsychiatric lupus
  • Chromatin antibodies – Primary use – diagnose drug-induced lupus, 50-90% of SLE patients have these antibodies, Related to proteinuria, glomerulonephritis, and disease activity, It’s not specific for SLE, Could be found in Sjögren syndromeand antiphospholipid syndrome (APS)
  • Biomarkers of lupus nephritis/disease severity:
    • Anti-C1q antibodies – existence of these antibodies can predict risk for severe of disease and it’s related to renal disease.
  • Consider the following testing to rule out other diseases:
    • Antiphospholipidantibodies icluding lupus anticoagulant, anticardiolipin, and anti-beta-2 glycoprotein 1 IgG and IgM assays
    • Cryoglobulin
      • Neurolupus: CSF is tested for cell count, glucose, oligoclonal bands, culture and Oligoclonal bands, Interleukin 6, 8, 10.
    • Collagen type VII antibody IgG – could be positive in bullous SLE
  • Routine tests:
  • Complete blood count. anemia commonly occurs in lupus. A low white blood cell or platelet count may occur in lupus as well.
  • Erythrocyte sedimentation rate (ESR) and C-Reactive Protein (CRP). ESR is usually elevated in active SLE, whereas CRP may not be.
  • liver transaminases.

References

  1. Fanouriakis A, Kostopoulou M, Alunno A, et al 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus Annals of the Rheumatic Diseases Published Online First: 29 March 2019. doi: 10.1136/annrheumdis-2019-215089

دیدگاهتان را بنویسید

نشانی ایمیل شما منتشر نخواهد شد. بخش‌های موردنیاز علامت‌گذاری شده‌اند *